A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients.
Validire P, Fermé C, Brice P, Diviné M, Gabarre J, Bouabdallah K, Fitoussi O, Chaoui D, Pacquement H, Soussain C, Carde P, Salhi R, Zanni M, Decaudin D.
Validire P, et al. Among authors: ferme c.
Anticancer Drugs. 2008 Mar;19(3):309-15. doi: 10.1097/cad.0b013e3282f46aec.
Anticancer Drugs. 2008.
PMID: 18510178